Home General News
Changes to Part VIIIB Specials Tariff
In February’s Drug Tariff the following changes to Part VIIIB will be effective:
Minimum Volume changes
The minimum pack size volumes have changed for the following products:
Product name | Previous volume | Amended to read |
Amisulpride 25mg/5ml oral suspension | 100ml | 150ml |
Amlodipine 10mg/5ml oral suspension | 100ml | 70ml |
Azathioprine 50mg/5ml oral suspension | 50ml | 100ml |
Clobazam 10mg/5ml oral suspension | 50ml | 100ml |
Clonazepam 500microgram/5ml oral suspension | 100ml | 150ml |
Gabapentin 250mg/5ml oral suspension | 100ml | 300ml |
Omeprazole 20mg/5ml oral suspension | 100ml | 150ml |
Primidone 50mg/5ml oral suspension | 100ml | 150ml |
Quetiapine 12.5mg/5ml oral suspension | 100ml | 150ml |
Price changes
Various products price have been updated for the February Drug Tariff. Contractors should make sure when placing orders in February for products listed in Part VIIIB, that their chosen supplier has updated their prices in line with the February Drug Tariff.
Contractors should be careful to ensure that any prescriptions received in January are submitted promptly for payment with January’s prescriptions, to avoid the risk of items being reimbursed at the February Drug Tariff price, which may be different from the prices they have been charged in January.
Deletion of Clobazam 5mg/5ml and 10mg/5ml oral solution
Due to the nature of the ingredient, Clobazam liquid can only be manufactured as an oral suspension, and not as an oral solution. As such the listings for Clobazam oral solutions have been removed from Part VIIIB.
Deletion of Ramipril 2.5mg/5ml oral solution
A newly licensed Ramipril 2.5mg/5ml oral solution preparation is now available, manufactured by Rosemont Pharmaceuticals; as such the listing for Ramipril 2.5mg/5ml oral solution has been removed from Part VIIIB and will be moved to Part VIIIA. A note in Part VIIIB will signposts the amendment, this will only remain for one month.
Posted 27 January 2012